Long-term Safety and Efficacy of Efgartigimod in Patients With Generalised Myasthenia Gravis

被引：0
|
作者：
Meisel, A. [1 ,2 ]
Bril, V. [3 ,4 ]
Vu, T. [5 ]
Karam, C. [6 ]
Peric, S. [7 ]
De Bleecker, J. [8 ]
Murai, H. [9 ]
Beydoun, S. [10 ]
Pasnoor, M. [11 ]
Guglietta, A. [12 ]
Ulrichts, P. [12 ]
T'joen, C. [12 ]
Utsugisawa, K. [13 ]
Verschuuren, J. [14 ]
Mantegazza, R. [15 ]
Howard, J. [16 ]
机构：
[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[2] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[3] Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA
[6] Univ Penn, Penn Neurosci Ctr, Philadelphia, PA USA
[7] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[8] Ghent Univ Hosp, Ghent, Belgium
[9] Int Univ Hlth & Welf, Sch Med, Dept Neurol, Tokyo, Japan
[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[11] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[12] Argenx, Ghent, Belgium
[13] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan
[14] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands
[15] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy
[16] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-021
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Brauer, Edward
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. NEUROLOGY, 2022, 99 (23) : S37 - S38
  • [2] LONG-TERM ASSESSMENT OF EFGARTIGIMOD IN PATIENTS WITH GENERALISED MYASTHENIA GRAVIS: ADAPT plus STUDY INTERIM RESULTS
    Jacob, Saiju
    Howard, James
    Bril, Vera
    Peric, Stojan
    De Bleecker, Jan
    T'joen, Carolin
    Travers, Jackalyne
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [3] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [4] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    [J]. MUSCLE & NERVE, 2022, 66 : S57 - S57
  • [5] Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
    Kim, Yool-hee
    Shin, Ha Young
    Kim, Seung Min
    [J]. YONSEI MEDICAL JOURNAL, 2019, 60 (07) : 633 - 639
  • [6] Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT plus Study
    Pasnoor, Mamatha
    Bril, Vera
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Vu, Tuan
    Ulrichts, Peter
    Van Hoorick, Benjamin
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    Howard, James
    [J]. NEUROLOGY, 2023, 100 (17)
  • [7] Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study
    Bril, Vera
    Pasnoor, Mamatha
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Vu, Tuan
    Ulrichts, Peter
    Van Hoorick, Benjamin
    T'Joen, Caroline
    Kaprielian, Roger
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    Howard, James F., Jr.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [8] Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT plus study
    Ashcraft, E.
    Bril, V.
    Pasnoor, M.
    Karam, C.
    Peric, S.
    De Bleecker, J.
    Murai, H.
    Meisel, A.
    Beydoun, S.
    Vu, T.
    Ulrichts, P.
    Van Hoorick, B.
    T'joen, C.
    Utsugisawa, K.
    Verschuuren, J.
    Mantegazza, R.
    Howard, J.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S179 - S179
  • [9] Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
    Sivadasan, Ajith
    Bril, Vera
    [J]. IMMUNOTHERAPY, 2023, 15 (08) : 553 - 563
  • [10] Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis
    Itani, Kumi
    Nakamura, Masataka
    Wate, Reika
    Kaneko, Satoshi
    Fujita, Kengo
    Iida, Shin
    Morise, Satoshi
    Murakami, Aya
    Kunieda, Takenobu
    Takenouchi, Norihiro
    Yakushiji, Yusuke
    Kusaka, Hirofumi
    [J]. NEUROMUSCULAR DISORDERS, 2021, 31 (06) : 512 - 518
12345